Curant Rare delivers fully integrated, end-to-end specialty pharmacy solutions purpose-built for rare and ultra-rare diseases, where complexity is high and traditional models fall short. We go beyond dispensing to provide a deeply personalized, high-touch experience that supports every stakeholder across the patient journey while driving measurable, real-world evidence and patient-reported outcomes.
Our therapy-focused care model is designed around the whole patient, not just the prescription. Dedicated clinical teams proactively identify and resolve barriers before they disrupt care, accelerating time to therapy, improving persistence, and ensuring patients remain supported well beyond initiation. From access and onboarding to long-term adherence and monitoring, we work side-by-side with patients, caregivers, and providers to simplify complexity and improve quality of life.
Through our validated Medication Care Management® approach, we deliver proactive, evidence-based interventions that enhance safety, adherence, and overall treatment success. At the same time, our proprietary data and analytics platform MedPlan Connect generates real-time insights and robust real-world evidence, equipping biopharma partners and providers with the visibility needed to optimize care pathways, measure impact, and continuously improve outcomes.
Unlike traditional specialty pharmacy models built for scale, Curant Rare is built for precision. Our exclusive, therapy-aligned approach ensures seamless coordination, consistent communication, and a level of clinical engagement that drives both patient success and partner confidence.
We don’t just support therapy, we strengthen the entire ecosystem around it. By combining high-touch care with actionable data, Curant Rare delivers clarity, continuity, and confidence at every step of the journey.
The diseases may be rare. The support shouldn’t be.